EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtVergleichsstudieOpen Access · CC BY-NC 4.0

Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis

Reza Sari Motlagh iD, Alireza Ghoreifi iD, Takafumi Yanagisawa iD, Tatsushi Kawada iD, Sascha Ahyai, Axel S Merseburger, Mohammad Abufaraj iD, Michael Abern, Hooman Djaladat iD, Siamak Daneshmand iD, Shahrokh F Shariat

BJU International · 2024

DOI: 10.1111/bju.16364 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift BJU International, 2024. Verfasst von Reza Sari Motlagh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystoscopy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the value of flexible blue‐light cystoscopy (BLC) vs flexible white‐light cystoscopy (WLC) in the surveillance setting of non‐muscle‐invasive bladder cancer (NMIBC).

Methods

All major databases were searched for articles published before May 2023 according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement. The primary outcome was the accuracy of flexible BLC vs WLC in detecting bladder cancer recurrence among suspicious bladder lesions.

Results

A total of 10 articles, comprising 1634 patients, were deemed eligible for the quantitative synthesis. In the meta‐analysis focusing on the detection of disease recurrence, there was no difference between flexible BLC and WLC (odds ratio [OR] 1.08, 95% confidence interval [CI] 0.82–1.41)]; the risk difference (RD) showed 1% of flexible BLC, corresponding to a number needed to treat (NNT) of 100. In the subgroup meta‐analysis of detection of carcinoma in situ (CIS) only, there was again no significant difference between flexible BLC and WLC (OR 1.19, 95% CI 0.82–1.69), BLC was associated with a RD of 2% (NNT = 50). The positive predictive values for flexible BLC and WLC in detecting all types of recurrence were 72% and 66%, respectively, and for CIS they were 39% and 29%, respectively.

Conclusion

Surveillance of NMIBC with flexible BLC could detect more suspicious lesions and consequently more tumour recurrences compared to flexible WLC, with a increase in the rate of false positives leading to overtreatment. A total of 100 and 50 flexible BLC procedures would need to be performed to find on additional tumor and CIS recurences, respectively. A risk‐stratified strategy for patient selection could be considered when using flexible BLC for the surveillance of NMIBC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystoscopyHumansNeoplasm Recurrence, LocalNeoplasm InvasivenessNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

CISbladder cancerblue‐light cystoscopycarcinoma in situflexible cystoscopyrecurrence

Autor:innen und Institutionen

  • Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Urology, Medical University of Graz, Graz, Austria.
  • Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.

ORCID-Profile: Reza Sari Motlagh, Alireza Ghoreifi, Takafumi Yanagisawa, Tatsushi Kawada, Mohammad Abufaraj, Hooman Djaladat, Siamak Daneshmand

Zitieren

APA

Sari Motlagh, R., Ghoreifi, A., Yanagisawa, T., Kawada, T., Ahyai, S., Merseburger, A. S., Abufaraj, M., Abern, M., Djaladat, H., Daneshmand, S., & Shariat, S. F. (2024). Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis. BJU International. https://doi.org/10.1111/bju.16364

Vancouver

Sari Motlagh R, Ghoreifi A, Yanagisawa T, Kawada T, Ahyai S, Merseburger AS, et al. Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis. BJU International. 2024. doi:10.1111/bju.16364

BibTeX
@article{SariMotlagh2024,
  author = {Sari Motlagh, Reza and Ghoreifi, Alireza and Yanagisawa, Takafumi and Kawada, Tatsushi and Ahyai, Sascha and Merseburger, Axel S and Abufaraj, Mohammad and Abern, Michael and Djaladat, Hooman and Daneshmand, Siamak and Shariat, Shahrokh F},
  title = {Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis},
  journal = {BJU International},
  year = {2024},
  doi = {10.1111/bju.16364}
}
Kostenlos starten →